Tondeur M, Ham H
Service des Radioisotopes, CHU Saint-Pierre, Brussels, Belgium.
Nucl Med Commun. 2000 Aug;21(8):781-3. doi: 10.1097/00006231-200008000-00013.
Patients often ask for the results after a radioisotope procedure, which can make nuclear medicine physicians feel uncomfortable. In Belgium, nuclear medicine physicians are not supposed to disclose results directly to patients, but to send them to the referring physician. We undertook this work to determine the official rules and practical attitudes in other countries. An introductory letter and a questionnaire were sent to 103 eminent nuclear medicine specialists from 37 countries. Seventy responses (32 countries) were received. Official rules seemed to exist in only seven countries. Most of the respondents indicated that their attitude depended on the clinical situation and the results of the test. Many respondents emphasized that, while in some situations the results should be communicated directly to patients in order to initiate treatment rapidly, in other situations, such as cancer, the referring physician was better suited to disclose the results. The advantages and drawbacks of different attitudes are discussed. Practically and universally applicable rules are difficult to establish, but choosing one solution remains preferable to no standardized attitude at all. An official body, including the medical community, representatives of the population and legal experts, should define an official rule which should be widely communicated, stressing its advantages and drawbacks. In practice, all nuclear medicine physicians would have to do would be to stick to the rule.
患者常常会在放射性同位素检查后询问结果，这可能会让核医学医生感到不自在。在比利时，核医学医生不应直接向患者透露结果，而是要将结果发送给转诊医生。我们开展这项工作是为了确定其他国家的官方规定和实际态度。我们给来自37个国家的103位知名核医学专家发送了一封介绍信和一份调查问卷。共收到70份回复（来自32个国家）。似乎只有七个国家存在官方规定。大多数受访者表示，他们的态度取决于临床情况和检查结果。许多受访者强调，虽然在某些情况下，为了迅速开始治疗，结果应直接告知患者，但在其他情况下，比如癌症，转诊医生更适合透露结果。文中讨论了不同态度的优缺点。虽然很难制定出实际且普遍适用的规则，但选择一种解决方案总比完全没有标准化态度要好。一个包括医学界、民众代表和法律专家在内的官方机构应该制定一条官方规定，并进行广泛宣传，同时强调其优缺点。在实际操作中，所有核医学医生只需遵守该规定即可。
